EZH2 and neoplasm: EZH2 is considered to be an oncogene, but inhibition of EZH2 activity in some solid tumors does not inhibit tumor growth due to changes in H3K27 trimethylation caused by EZH2 and also causes changes in H3K27 acetylation (Huang et al., 2018).